Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 ...

Abbott beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its medical devices ...

Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...

"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...